SCHEMBL7770211

SCHEMBL7770211

Oc1c(I)c(O)c(I)c(O)c1I

nearest known ligand 0.53

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL68832 0.89 TTR (0.35) TTR
SCHEMBL19730540 0.84 TTR (0.33) TTR
SCHEMBL1686815 0.84 TTR (0.33) TTR
SCHEMBL21937056 0.80 TTR (0.33) TTR
SCHEMBL1686653 0.74
SCHEMBL22991554 0.73 GABRA1 (0.33)
SCHEMBL23957245 0.73 TTR (0.39) TTR
SCHEMBL22991538 0.73
SCHEMBL25147640 0.71 TTR (0.33) TTR
SCHEMBL1686478 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114583262-B Electrolyte and lithium ion battery 比亚迪股份有限公司 2024-10-11 CN claimed
CN-118108927-A Porous organic polymer containing hydroxyl and porphyrin groups, and preparation method and application thereof 右江民族医学院 2024-05-31 CN claimed
CN-114583262-A Electrolyte and lithium ion battery 比亚迪股份有限公司 2022-06-03 CN claimed
CN-112724373-B Functional organic porous polymer and preparation method and application thereof 山东大学 2021-09-21 CN claimed
CN-112724373-A Functional organic porous polymer and preparation method and application thereof 山东大学 2021-04-30 CN claimed
EP-1124790-A1 BIODEGRADABLE NONIONIC CONTRAST MEDIA BIOPHYSICA, INC. (US) 2001-08-22 EP claimed
US-6072069-A Biodegradable nonionic contrast media BIOPHYSICA, INC. (US) 2000-06-06 US claimed
WO-2000026179-A1 BIODEGRADABLE NONIONIC CONTRAST MEDIA BIOPHYSICA INC (US) 2000-05-11 WO claimed
EP-4688006-A1 CATALYST-FREE RADIOPAQUE MEDICAL HYDROGELS AND SYSTEMS FOR FORMING SAME Boston Scientific Scimed Inc. (US) 2026-02-11 EP disclosed
WO-2025096930-A1 AMINO-ACID- AND AMINO-ALCOHOL-BASED POLYAMINE COMPOUNDS AND MEDICAL HYDROGELS FORMED THEREFROM BOSTON SCIENTIFIC SCIMED, INC. (US) 2025-05-08 WO disclosed
US-20250136760-A1 AMINO-ACID- AND AMINO-ALCOHOL-BASED POLYAMINE COMPOUNDS AND MEDICAL HYDROGELS FORMED THEREFROM BOSTON SCIENTIFIC SCIMED, INC. (US) 2025-05-01 US disclosed
CN-114583262-B Electrolyte and lithium ion battery 比亚迪股份有限公司 2024-10-11 CN disclosed
WO-2024206160-A1 CATALYST-FREE RADIOPAQUE MEDICAL HYDROGELS AND SYSTEMS FOR FORMING SAME BOSTON SCIENTIFIC SCIMED, INC. (US) 2024-10-03 WO disclosed
US-20240316220-A1 CATALYST-FREE RADIOPAQUE MEDICAL HYDROGELS AND SYSTEMS FOR FORMING SAME BOSTON SCIENTIFIC SCIMED, INC. (US) 2024-09-26 US disclosed
US-5468466-A Compositions of iodophenyl sulfonates for X-ray visualization of the gastrointestinal tract STERLING WINTHROP, INC. (US) 1995-11-21 US disclosed
US-5372800-A X-ray contrast coating STERLING WINTHROP INC. (US) 1994-12-13 US disclosed
EP-0617969-A2 Compositions of iodophenyl esters and iodophenyl sulfonates for visualization of the gastrointestinal tract NYCOMED IMAGING AS (NO) 1994-10-05 EP disclosed
EP-0617970-A2 Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastrointestinal tract NYCOMED IMAGING AS (NO) 1994-10-05 EP disclosed
US-5336484-A Contrast compound comprising an iodobenzene ester and a Group 2A metal salt of a carboxylated or sulfonated polysaccharide in a carrier; uniform coating; radiology STERLING WINTHROP INC. (US) 1994-08-09 US disclosed
US-5318769-A Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract STERLING WINTHROP INC. (US) 1994-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240316220-A1 CATALYST-FREE RADIOPAQUE MEDICAL HYDROGELS AND SYSTEMS FOR FORMING SAME XRCC5, CAD, RAD18 TTR 2648/4885
US-20250136760-A1 AMINO-ACID- AND AMINO-ALCOHOL-BASED POLYAMINE COMPOUNDS AND MEDICAL HYDROGELS FORMED THEREFROM CARM1, PNMT, ADM2 TTR 4598/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.